BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marlatt KL, Lovre D, Beyl RA, Tate CR, Hayes EK, Burant CF, Ravussin E, Mauvais-Jarvis F. Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women. Eur J Endocrinol 2020;183:439-52. [PMID: 32698159 DOI: 10.1530/EJE-20-0619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi L, Xu X, Xiang G, Duan S. Anti-osteoporosis treatments changed body composition in postmenopausal women: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e30522. [PMID: 36086691 DOI: 10.1097/MD.0000000000030522] [Reference Citation Analysis]
2 Karppinen JE, Juppi HK, Hintikka J, Wiklund P, Haapala EA, Hyvärinen M, Tammelin TH, Aukee P, Kujala UM, Laukkanen J, Laakkonen EK. Associations of resting and peak fat oxidation with sex hormone profile and blood glucose control in middle-aged women. Nutr Metab Cardiovasc Dis 2022:S0939-4753(22)00251-4. [PMID: 35752543 DOI: 10.1016/j.numecd.2022.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, Kohrt WM. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022;30:14-27. [PMID: 34932890 DOI: 10.1002/oby.23289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
4 Marlatt KL, Lovre D, Beyl RA, Tate CR, Hayes EK, Burant CF, Ravussin E, Mauvais-Jarvis F. Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women. Eur J Endocrinol 2020;183:439-52. [PMID: 32698159 DOI: 10.1530/EJE-20-0619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]